Arcutis Biotherapeutics, Inc. — All Filings
773 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000405 | Mar 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-014642 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-014639 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | FORM 4 | 0001628280-26-014328 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001628280-26-014327 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001628280-26-014326 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001628280-26-014325 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | FORM 4 | 0001628280-26-014324 | Mar 3, 2026 | Aug 18, 2022 |
| 144 | — | 0001628280-26-013464 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013438 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013436 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013435 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013433 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013420 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013371 | Mar 2, 2026 | — |
| S-8 | S-8 | 0001787306-26-000021 | Feb 25, 2026 | — |
| S-3ASR | S-3ASR | 0001787306-26-000020 | Feb 25, 2026 | — |
| 10-K | 10-K | 0001787306-26-000018 | Feb 25, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001787306-26-000017 | Feb 25, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015201 | Feb 13, 2026 | — |
| 4 | FORM 4 | 0001628280-26-005582 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005571 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005570 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005568 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005567 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005566 | Feb 4, 2026 | Feb 2, 2026 |
| 144 | — | 0001628280-26-005499 | Feb 4, 2026 | — |
| 144 | — | 0001628280-26-004731 | Feb 2, 2026 | — |
| 144 | — | 0001628280-26-004728 | Feb 2, 2026 | — |
| 144 | — | 0001628280-26-004725 | Feb 2, 2026 | — |
| 144 | — | 0001628280-26-004714 | Feb 2, 2026 | — |
| 144 | — | 0001628280-26-004705 | Feb 2, 2026 | — |
| 144 | — | 0001628280-26-004686 | Feb 2, 2026 | — |
| SCHEDULE 13G/A | — | 0000053417-26-000007 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0001628280-26-001241 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001628280-26-000969 | Jan 6, 2026 | Jan 2, 2026 |
| 144 | — | 0001628280-26-000401 | Jan 5, 2026 | — |
| 4 | FORM 4 | 0001628280-26-000209 | Jan 2, 2026 | Dec 31, 2025 |
| 144 | — | 0001628280-26-000117 | Jan 2, 2026 | — |
| 144 | — | 0001628280-25-059201 | Dec 31, 2025 | — |
| 4 | FORM 4 | 0001741987-25-000010 | Dec 17, 2025 | Dec 15, 2025 |
| 144 | — | 0001628280-25-057008 | Dec 15, 2025 | — |
| 4 | FORM 4 | 0001628280-25-055927 | Dec 8, 2025 | Dec 4, 2025 |
| 3 | FORM 3 | 0001628280-25-055925 | Dec 8, 2025 | Dec 4, 2025 |
| 8-K | 8-K | 0001787306-25-000147 | Dec 8, 2025 | Dec 3, 2025 |
| 4 | FORM 4 | 0001798679-25-000007 | Dec 3, 2025 | Dec 1, 2025 |
| 4 | FORM 4 | 0001801050-25-000008 | Dec 3, 2025 | Dec 1, 2025 |
| 144 | — | 0001628280-25-054427 | Dec 1, 2025 | — |
| 144 | — | 0001628280-25-054424 | Dec 1, 2025 | — |
| 4 | FORM 4 | 0001867788-25-000005 | Nov 25, 2025 | Nov 24, 2025 |